Received: 3 December 2021
Accepted: 11 July 2022
First Online: 25 August 2022
: The Ethics Review Board of the Canton of Zurich waived the necessity for a formal ethics evaluation for this study based on the Swiss Law on Research on Humans (Nr. Req-2016-00386).
: All authors and acknowledged individuals have provided their consent for publication.
: PWS received travel grants from Pfizer and Gilead, speaker fees from Pfizer and fees for advisory board activity from Pfizer and Gilead outside of the submitted work. HS received travel grants and/or speakers honorary from AstraZeneca, Livinguard, and agfam outside of the submitted work.